Manar Al Junaidi
Department of Pharmacy and Medical Sciences, clinical pharmacy and practice, Hebron, Jerusalem, IsraelPublications
-
Research Article
A comparative Study of Long Acting Injectable Antipsychotic Agents and Oral Agents during COVID-19 Pandemic: Quality of Life, Adherence and Shortage of Supply
Author(s): Muamar MA Shaheen*, Sara Al Saghair, Hamzah Obeido, Basema Al Kurd, Ibrahim Al Zaro and Manar Al Junaidi
Background: Long-acting injectable antipsychotics improved markedly patient adherence to psychotropic agents during the past decade. They were used mainly for long-term treatment of schizophrenia. However their role in short term or intermittent use or their effect on quality of life was not elucidated clearly. Objectives: To assess the impact of Long Acting Antipsychotic agents on quality of life of schizophrenic patients. Methods: This is a retrospective cohort study of psychiatric patients who were taking LAIs and/or oral antipsychotic drugs at Mohammad Said Kamal Hospital for Mental Illness in Bethlehem and Mental Health Clinic of The Ministry of Health in Hebron city during the period of September 2019 to March 2020. Results: Fifty one patients were included in this study, 74% males, age 50.69 ± 11.14 years old. Average duration of psychiatric disease .. Read More»